ASCO 2023 | Unmet needs in extrapulmonary neuroendocrine carcinomas

Nikolaos Trikalinos, MD, MS, Washington University, St. Louis, MO, comments on remaining challenges in the management of extrapulmonary neuroendocrine carcinomas. Whilst response rates have been improving over the past few years, patients who progress on current treatments need alternative therapies. Additional strategies are needed to maintain remission for those are in remission. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.